Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 05, 2016 08:25 ET | Source: Allarity Therapeutics, Inc.

MPI and Oncology Venture enhances the collaboration by entering another agreement on DRP's

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Hoersholm; July 5th, 2016 - Medical...
June 21, 2016 03:29 ET | Source: Allarity Therapeutics, Inc.

MPI is listing on Nasdaq Stockholm First North. First day of trading is June 27th 2016

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Hoersholm; June 21, 2016 - Medical...
June 14, 2016 10:18 ET | Source: Allarity Therapeutics, Inc.

MPI - update on warrant program

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Hoersholm; June 14, 2016 - Medical...
June 09, 2016 16:16 ET | Source: Allarity Therapeutics, Inc.

MPI - Up-date on date of first day of trading on Nasdaq First North Stockholm

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Hoersholm June 9th 2016 - Medical...
June 08, 2016 08:24 ET | Source: Allarity Therapeutics, Inc.

MPI giver meddelelse om storaktionærers ændringer af aktiebesiddelser jf. værdipapirhandelslovens §29.

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Hørsholm; 8. juni 2016 - Medical...
June 02, 2016 04:51 ET | Source: Allarity Therapeutics, Inc.

Meet MPI at SACHS Immuno-Oncology BD&L, Chicago; ASCO, American Society of Clinical Oncology, Chicago; BIO in San Francisco

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Company News JUNE 3rd: APO010 *Oncology...
May 31, 2016 09:30 ET | Source: Allarity Therapeutics, Inc.

MPI's DRP used in the first prospective study

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Hoersholm, Denmark; May 31st, 2016 -...
May 26, 2016 04:57 ET | Source: Allarity Therapeutics, Inc.

MPI - presents at Sedermeradagen in Gothenburg

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} On the 1st of June 2016, Medical...
May 12, 2016 14:01 ET | Source: Allarity Therapeutics, Inc.

MPI - Positive data on MPI's DRP for 5-FU published in PLOS ONE

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Hoersholm, Denmark; May 12th, 2016 -...
May 03, 2016 04:36 ET | Source: Allarity Therapeutics, Inc.

MPI - Process Started Regarding Change of Marketplace

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Hoersholm, May 3 2016 - Medical Prognosis...